New Haven, CT3 Active Studies

Scleroderma Clinical Trials in New Haven, CT

Find 3 actively recruiting scleroderma clinical trials in New Haven, CT. Connect with local research sites and explore new treatment options.

3
Active Trials
3
Sponsors
718
Enrolling

Recruiting Scleroderma Studies in New Haven

About Scleroderma Clinical Trials in New Haven

Scleroderma is an autoimmune connective tissue disease characterized by hardening and tightening of the skin and connective tissues. Systemic sclerosis can also affect internal organs including lungs, kidneys, and heart. Treatment is directed at specific symptoms and organ involvement.

There are currently 3 scleroderma clinical trials recruiting participants in New Haven, CT. These studies are seeking a combined 718 participants. Research is being sponsored by Scleroderma Research Foundation, Inc., AstraZeneca, Cabaletta Bio. Clinical trial participation is free and participants receive study-related medical care at no cost.

Scleroderma Clinical Trials in New Haven — FAQ

Are there scleroderma clinical trials in New Haven?

Yes, there are 3 scleroderma clinical trials currently recruiting in New Haven, CT. Browse the studies on this page to find one that fits.

How do I join a clinical trial in New Haven?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the New Haven research site will contact you about next steps.

Are clinical trials in New Haven free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many New Haven studies also compensate for your time and travel.

What scleroderma treatments are being tested?

The 3 active trials in New Haven are testing new therapies including novel drugs, biologics, and treatment approaches for scleroderma.

Data updated March 2, 2026 from ClinicalTrials.gov